Global Antiviral Drugs Market, By Drug Class (DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, m-RNA Synthesis Inhibitors, Integrase Inhibitors, Others), Indication (HIV, Hepatitis, Herpes Simplex Virus, Influenza, Others), Route of Administration (Oral, Topical, Parenteral Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa), Market Trends and Forecast to 2027.
Market Analysis and Insights: Global Antiviral Drugs Market
Global antiviral drugs market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market is growing at a healthy CAGR in the above-mentioned research forecast period. Emerging markets and huge investment in research and development are the factors responsible for the growth of this market.
The factors responsible for the growth of antiviral drugs market are vulnerable population of viral infections such as respiratory syncytial virus as well as influenza and high adoption of antiviral therapies. In addition, advances in the formulation such as fixed dose combination and high demand of diseases specific treatment are some of the impacting factors for the demand of antiviral drugs. Nevertheless, huge financial involvements in the research and development activities coupled with adoption of alternative medicines are the factors that hinder the growth of this market.
Antiviral drugs are the class of antimicrobials therapeutics which is used widely in the treatment of viral infections. The antiviral agents have distinct mechanism of action which includes the inhibition of viral DNA synthesis and hence prevent it from replication. Some antiviral drugs acts on protease enzymes and prevent it from cell division.
Antiviral drugs market provides details of market share, new developments and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.
Global Antiviral Drugs Market Scope and Market Size
Antiviral drugs market is segmented on the basis of drug class, indication, route of administration, end-users and distribution channel.
- On the basis of drug class, the global antiviral drugs market is segmented into DNA polymerase inhibitors, reverse transcriptase inhibitors, protease inhibitors, m-RNA synthesis inhibitors, integrase inhibitors and others.
- Based on indication, the global antiviral drugs market is segmented into HIV, hepatitis, herpes simplex virus, influenza and others.
- Route of administration segment of global antiviral drugs market is segmented into oral, topical and others.
- On the basis of end-users, the global antiviral drugs market is segmented into hospitals, homecare, specialty clinics and others.
- On the basis of distribution channel, the global antiviral drugs market has been bifurcated into hospital pharmacy, online pharmacy and retail pharmacy.
Global Antiviral Drugs Market Country Level Analysis
Antiviral drugs market is analyzed and market size information is provided by country, drug class, route of administration, end-users and distribution channel as referenced above.
The countries covered in the global antiviral drugs market report are U.S., Canada, Mexico in North America, Brazil, Argentina, Peru, Rest of South America, as part of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, in the Asia-Pacific, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa, as a part of Middle East and Africa.
North America region is likely to hold majority of the market share for antiviral drugs market owing to high prevalence of viral diseases, presence of global key market players and availability of sophisticated treatment. Europe is considered a second largest growing regional segment due to the high diagnosis rate and developed healthcare infrastructure. Asia-Pacific leads the market due to the developing healthcare facilities and rise in government initiatives.
The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Patient Epidemiology Analysis
Global antiviral drugs market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analyzed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
Competitive Landscape and Global Antiviral Drugs Market Share Analysis
Global antiviral drugs market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to global antiviral drugs market.
The major players covered in the global antiviral drugs market are Merck & Co., Inc., F. Hoffmann-La Roche Ltd, Johnson & Johnson Services, Inc, GlaxoSmithKline plc, Hetero, Mylan N.V., Aurobindo Pharma, Cipla Inc, Laurus Labs Ltd, Micro Labs Ltd, Inc, Gilead Sciences, Inc, Sun Pharmaceutical Industries Ltd, Amneal Pharmaceuticals LLC, Alembic Pharmaceuticals Limited, Lupin, Novartis AG, Zydus Pharma, and Bausch Health among others.
Customization Available : Global Antiviral Drugs Market
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.